Jove
Visualize
Contact Us

Related Experiment Videos

HIV-1 associated encephalopathy and myelopathy.

Ch Eggers1,

  • 1Neurologische Klinik des Universitäts-klinikums Hamburg Eppedndorf, Germany. eggers@uke.uni-hamburg.de

Journal of Neurology
|November 8, 2002
PubMed
Summary

HIV-1-associated encephalopathy (HIVE) and HIV-1 associated myelopathy (HIVM) are serious CNS complications of advanced HIV infection. This paper details current research, diagnosis, and treatment for these debilitating neurological conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Treatment of acute and chronic psychoses in childhood and adolescence].

MMW Fortschritte der Medizin·2006
Same author

[Migraine accompagnés childhood].

Monatsschrift fur Kinderheilkunde·1977
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neurology
  • Virology
  • Immunology

Background:

  • HIV-1-associated encephalopathy (HIVE) and HIV-1 associated myelopathy (HIVM) are significant neurological complications in advanced HIV infection.
  • Despite antiretroviral therapy advancements, specific pharmacological and virological conditions in the central nervous system (CNS) contribute to HIVE and HIVM.
  • HIVE presents as subcortical dementia with psychomotor slowing, memory, and concentration deficits, alongside invariable central motor function impairment.

Framework:

  • Enhanced viral replication in immunocompetent CNS cells is the proposed pathogenic mechanism for HIVE and HIVM.
  • Neurotoxic effects result from direct viral products and indirect immune responses within the CNS.
  • This consensus paper provides recommendations for diagnosing and treating HIVE and HIVM.

Implementation:

  • Focus on diagnostic criteria for HIVE and HIVM.
  • Outline current therapeutic strategies for managing CNS HIV complications.
  • Summarize the state of ongoing research in the field.

Implications:

  • Improved understanding of HIVE and HIVM pathogenesis.
  • Standardized diagnostic and therapeutic protocols for CNS HIV manifestations.
  • Guidance for future research directions in neuro-HIV.

Related Experiment Videos